[HTML] nih.gov

[HTML][HTML] Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

S Hu, Y Huang, Y Chen, R Zhou, X Yang… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Osteoporosis is a systemic skeletal disorder and occurs frequently in
postmenopausal women and older men. This study aimed to examine whether diosmetin …
被引用次数：4 相关文章
[HTML] amegroups.org

[HTML][HTML] Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

S Hu, Y Huang, Y Chen, R Zhou, X Yang… - Annals of …, 2020 - atm.amegroups.org
Background: Osteoporosis is a systemic skeletal disorder and occurs frequently in
postmenopausal women and older men. This study aimed to examine whether diosmetin …

Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

S Hu, Y Huang, Y Chen, R Zhou… - Annals of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Osteoporosis is a systemic skeletal disorder and occurs frequently in
postmenopausal women and older men. This study aimed to examine whether diosmetin …

Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats.

S Hu, Y Huang, Y Chen, R Zhou, X Yang… - Annals of …, 2020 - europepmc.org
Background Osteoporosis is a systemic skeletal disorder and occurs frequently in
postmenopausal women and older men. This study aimed to examine whether diosmetin …
[PDF] amegroups.cn

[PDF][PDF] Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

S Hu, Y Huang, Y Chen, R Zhou, X Yang, Y Zou, D Gao… - 2020 - cdn.amegroups.cn
Background: Osteoporosis is a systemic skeletal disorder and occurs frequently in
postmenopausal women and older men. This study aimed to examine whether diosmetin …
[PDF] semanticscholar.org

[PDF][PDF] Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

S Hu, Y Huang, Y Chen, R Zhou, X Yang, Y Zou, D Gao… - 2020 - pdfs.semanticscholar.org
Background: Osteoporosis is a systemic skeletal disorder and occurs frequently in
postmenopausal women and older men. This study aimed to examine whether diosmetin …

[引用][C] Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1 in osteoporosis rats

S Hu, Y Huang, Y Chen, R Zhou, X Yang… - Annals of …, 2020 - atm.amegroups.org
Diosmetin reduces bone loss and osteoclastogenesis by regulating the expression of TRPV1
in osteoporosis rats - Hu - Annals of Translational Medicine Have a website account?Log In …